Astrazeneca Pharmaceuticals Lp V. Natco Pharma Limited - 3:24-cv-10624

Astrazeneca Pharmaceuticals Lp V. Natco Pharma Limited (Case No. 3:24-cv-10624), filed on Nov 20, 2024 in the District Court, D. New Jersey involving patent infringement. This case involves patent infringement claims between the parties. Explore details about the litigants, key filings, and major docket updates.

Case Details

Case Number
3:24-cv-10624
Filing Date
Nov 20, 2024
Cause of Action
Patent Infringement
Status
-
Court
District Court, D. New Jersey
Nature of Suit
Patent - Abbreviated New Drug Application(ANDA)

Parties Involved

The following parties are involved in this case, with their respective legal representatives for the case.

NameRepresented By
ASTRAZENECA UK LIMITED -
MSD INTERNATIONAL BUSINESS GMBH -
KUDOS PHARMACEUTICALS LIMITED -
NATCO PHARMA LIMITED -

Patents Involved

Patents not found - set an alert to get notified when patents are added.

Docket Entries

The Docket Entries section provides a chronological list of all significant filings and court actions in this case.

DateDocket EntryType

Set alerts for critical docket entry

Nov 20, 2024COMPLAINT against NATCO PHARMA INC., NATCO PHARMA LIMITED ( Filing and Admin fee $ 405 receipt number ANJDC-15822158), Related Case Selected, filed by KUDOS PHARMACEUTICALS LIMITED, ASTRAZENECA PHARMACEUTICALS LP, ASTRAZENECA AB, ASTRAZENECA UK LIMITED, MSD INTERNATIONAL BUSINESS GMBH. (Attachments: # 1 Exhibit A ('810 patent), # 2 Certification (Rule 11.2), # 3 Civil Cover Sheet)(CHEVALIER, CHARLES) (Entered: 11/20/2024)PACER Document
Nov 20, 2024Corporate Disclosure Statement by MSD INTERNATIONAL BUSINESS GMBH identifying Merck & Co., Inc. as Corporate Parent.. (CHEVALIER, CHARLES) (Entered: 11/20/2024)PACER Document
Nov 20, 2024Corporate Disclosure Statement by KUDOS PHARMACEUTICALS LIMITED identifying AstraZeneca PLC as Corporate Parent.. (CHEVALIER, CHARLES) (Entered: 11/20/2024)PACER Document
Nov 20, 2024Corporate Disclosure Statement by ASTRAZENECA AB identifying AstraZeneca PLC as Corporate Parent.. (CHEVALIER, CHARLES) (Entered: 11/20/2024)PACER Document
Nov 20, 2024Corporate Disclosure Statement by ASTRAZENECA UK LIMITED identifying AstraZeneca PLC as Corporate Parent.. (CHEVALIER, CHARLES) (Entered: 11/20/2024)PACER Document
Nov 20, 2024Corporate Disclosure Statement by ASTRAZENECA PHARMACEUTICALS LP identifying AstraZeneca PLC as Corporate Parent.. (CHEVALIER, CHARLES) (Entered: 11/20/2024)PACER Document
Nov 21, 2024AO120 Patent/Trademark Form filed. (Attachment(s) # 1 Complaint, # 2 Exhibit) (mlh). (Entered: 11/21/2024)PACER Document
Nov 21, 2024SUMMONS ISSUED as to NATCO PHARMA INC. and NATCO PHARMA LIMITED. Attached is the official court Summons, please fill out Defendant and Plaintiffs attorney information and serve. (mlh) (Entered: 11/21/2024)PACER Document
Dec 3, 2024WAIVER OF SERVICE Returned Executed by KUDOS PHARMACEUTICALS LIMITED, ASTRAZENECA PHARMACEUTICALS LP, ASTRAZENECA AB, ASTRAZENECA UK LIMITED, MSD INTERNATIONAL BUSINESS GMBH. NATCO PHARMA INC. waiver sent on 11/20/2024, answer due 1/20/2025. (CHEVALIER, CHARLES) (Entered: 12/03/2024)PACER Document
Dec 3, 2024WAIVER OF SERVICE Returned Executed by KUDOS PHARMACEUTICALS LIMITED, ASTRAZENECA PHARMACEUTICALS LP, ASTRAZENECA AB, ASTRAZENECA UK LIMITED, MSD INTERNATIONAL BUSINESS GMBH. NATCO PHARMA LIMITED waiver sent on 11/20/2024, answer due 1/20/2025. (CHEVALIER, CHARLES) (Entered: 12/03/2024)PACER Document
Dec 4, 2024NOTICE of Appearance by JAMES S. RICHTER on behalf of NATCO PHARMA LIMITED, NATCO PHARMA INC. (RICHTER, JAMES) (Entered: 12/04/2024)PACER Document
Dec 20, 2024STIPULATION AND ORDER that Civil Action Nos. 3:24-10458, 3:24-10624, 3:24-10627, 3:24-10628, and 3:24-10629 are hereby consolidated for all pretrial purposes and that all papers be maintained in Civil Action No. 3:23-796. Signed by Magistrate Judge Tonianne J. Bongiovanni on 12/20/2024. (kht) (Entered: 12/20/2024)PACER Document
Nov 20, 2024Judge Robert Kirsch and Magistrate Judge Tonianne J. Bongiovanni added. (mlh)PACER Document